Posted inBiotechnology
Navigating Complexity in Future Food System Models
In the evolving landscape of global food systems, the intricate web of environmental, social, health, and economic factors presents profound…
Posted inBiotechnology
Advancing Secure and Portable DNA Sequencing
In the fast-evolving world of genomics, the rise of portable sequencing devices marks a pivotal shift, promising unprecedented accessibility to…
Posted inBiotechnology
MR Urography Assesses Pediatric UPJ Obstruction Treatment
Recent advancements in pediatric imaging have unveiled cutting-edge techniques that significantly enhance diagnostic capabilities for common urological conditions in children.…
Posted inBiotechnology
Lyell hands over $70M-plus in cash, equity for ‘impressive’ phase 1-stage colorectal cancer CAR-T
In a licensing deal unveiled Monday, Lyell Immunopharma is handing over $40 million in cash and almost 2 million of…
Posted inMedical Technology
DNA test maker BillionToOne raises $314M in IPO, shares take a quick dip
Molecular diagnostics firm BillionToOne raised $314 million in the DNA test maker’s upsized initial public offering but saw share values…
Posted inMedical Technology
Guardant blood test gives early warning of cancer progression in chemo patients, study finds
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is…
Posted inBiotechnology
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed
Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS)…
Posted inBiotechnology
miR-770-5p Regulates KLF4/EGFR via PRMT5
In the rapidly evolving landscape of molecular oncology, a groundbreaking discovery has emerged that could redefine therapeutic strategies against several…
Posted inBiotechnology
New Genomic Tools Boost European Flax Breeding
In a remarkable leap forward for agricultural genomics, researchers have unveiled a comprehensive chromosome-scale assembly of the European flax, scientifically…
Posted inBiotechnology
AstraZeneca’s $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win
AstraZeneca's aldosterone synthase inhibitor baxdrostat reduced blood pressure by 14 mmHg over 12 weeks, the pharma has said in a…